Watch CBSN Live

Insulin makers grilled on price surge, as diabetics struggle to afford life-saving meds

Pressure from Congress appears to be spurring the pharmaceutical industry to lower prescription drug prices for some patients. One of the main producers of insulin, Sanofi, said it will cap the cost of the life-saving drug for diabetics. Some could save thousands of dollars a year. Anna Werner reports.
View CBS News In
CBS News App Open
Chrome Safari Continue